Method of treating gastroesophageal reflux disease and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/195 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61K 31/197 (2006.01)

Patent

CA 2449009

A method of concurrent treatment for gastroesophageal reflux disease and nocturnal acid breakthrough is described, which comprises the delivery of an GABAb receptor agonist such as 4-amino-3-(4-chlorophenyl) butanoic acid, in the evening, in a gastric retained drug delivery system.

L'invention concerne une méthode permettant de traiter concurremment un reflux gastroesophagien pathologique et une sécrétion d'acide nocturne, consistant à administrer un agoniste du récepteur de GABAb, notamment de l'acide 4-amino-3-(4-chlorophényl) butanoïque, le soir, à l'aide d'un système d'administration d'un médicament retenu dans l'estomac.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating gastroesophageal reflux disease and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating gastroesophageal reflux disease and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating gastroesophageal reflux disease and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1391356

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.